Sources: 44NIH Clinical Center, 4ClinicalTrials, 6Cochrane Library, 65UMLS, 43NDF-RT, 13DrugBank, 26HMDB, 9DGIdb, 53PharmGKB, 30IUPHAR, 47Novoseek, 1BitterDBSee all MalaCards sources |
Drugs for Trigeminal Neuralgia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 86)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Triamcinolone | approved | Phase 4 | 448 | 124-94-7 | 31307 | (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione 11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione 124-94-7 4-08-00-03629 (Beilstein Handbook Reference) 83474-03-7 9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-16-alpha-hydroxyprednisolone 9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy 9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione 9alpha-Fluoro-16alpha-hydroxyprednisolone 9α-fluoro-16α-hydroxyprednisolone AC-2072 AC1L1LDH AC1Q5HJC Adcortyl Allernaze Aristocort Aristocort A Aristocort Tablets Aristogel Aristospan Azmacort BPBio1_000154 BRD-K77554836-001-03-3 BRN 2341955 BSPBio_000140 Bio-0662 C21H27FO6 CHEMBL1451 CID31307 CL 19823 Celeste Cinolone Cinolone-T D00385 D014221 DB00620 Delphicort EINECS 204-718-7 EU-0101179 Fluoxiprednisolone Fluoxyprednisolone Flutex Fougera HMS1568G22 HMS2090D12 HSDB 3194 Kenacort Kenacort (TN) Kenacort-A Kenacort-AG Kenacort-Ag Kenalog Kenalog in Orabase Kenalog-10 Kenalog-40 Kenalog-H LS-698 Ledercort Lopac0_001179 MLS000028542 MLS001066543 | MLS002695935 MolPort-002-528-981 Mycolog NCGC00021580-03 NCGC00021580-04 NCGC00021580-05 NCGC00021580-06 NCGC00021580-07 NCI60_000750 NSC 13397 NSC13397 Nasacort Nasacort Aq Nasacort Hfa Omcilon Omicilon Oracort Oralone Orion Polcortolon Pregna-1,4-diene-3,20-dio Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha) Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI) Prestwick0_000120 Prestwick1_000120 Prestwick2_000120 Prestwick3_000120 Prestwick_438 Rodinolone S1933_Selleck SK-Triamcinolone SMP1_000300 SMR000058333 SPBio_002079 Sk-Triamcinolone T6376_SIGMA TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7)) Tiamcinolonum Tiamcinolonum [INN-Latin] Tri-Nasal Triacet Triacort Triam-Tablinen Triamcet Triamcinalone Triamcinlon Triamcinolon Triamcinolona Triamcinolona [INN-Spanish] Triamcinolone (JP15/USP/INN) Triamcinolone Acetonide Triamcinolone [USAN:INN:BAN:JAN] Triamcinolone acetonide Triamcinolone diacetate Triamcinolone hexacetonide Triamcinolonum Triamcinolonum [INN] Trianex Triatex Tricortale Triderm Triesence Trilone Tristoject Trymex UNII-1ZK20VI6TY Vetalog Volon Volon A WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ ZINC03882036 droxypregna-1,4-diene-3,20-dione ione nchembio.2007.53-comp7 triamcinolone | |
| | 2 | | Artemether | approved | Phase 4 | 138 | 71963-77-4 | 119380, 68911 | ( )-alpha-Artemether (1R,4S,5R,8S,9R,10S,12R,13R)-10-Methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane (3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepine (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin (3alpha,5abeta,6beta,8abeta,9alpha,10beta,12beta,12aR*)-isomer of artemether (3r,5as,6r,8as,9r,10r,12r,12ar)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene (5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene .beta.-Artemether .beta.-Dihydroartemisinin methyl ether .beta.-Methylether of 11-epi-dihydroartemisinin 10-Methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane 10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane 159573-83-8 3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-tri 71939-51-0 71963-77-4 74784-06-8 80286-56-2 93787-85-0 AC1L2APD AC1L2XO8 AC1L9SH2 AC1L9UV0 AC1MI2ZX AC1Q6Z74 AC1Q6Z7V AR-1A4424 Arteannuin ether Artemetero Artemetero [INN-Spanish] Artemether Artemether (INN) Artemether [INN] Artemetheri Artemetherum Artemetherum [INN-Latin] Artemisininelactol methyl ether Artemos Artenam Artesaph Artesian Artimist Artmether BRN 5948416 C16H26O5 CHEBI:195280 | CHEMBL411864 CHEMBL512315 CID10266705 CID104888 CID3062122 CID456408 CID500199 CID6483308 CID6712286 CID68911 CID9796294 CID9796295 CPD000469218 D02483 DB06697 Dihydroartemisinin methyl ether Dihydroqinghaosu methyl ether Dihydroquinghaosu methyl ether Falcidol Gvither HMS2052L09 HSDB 7456 I06-0205 KST-1A8041 LS-176935 LS-64237 MLS001424249 Malartem Methyl-dihydroartemisinine NCI60_022891 NSC 665970 NSC665970 O-Methyldihydroartemisinine Paluther S2264_Selleck SAM001246799 SM 224 SM 229 SM-224 SMR000469218 UNII-C7D6T3H22J alpha-Artemether alpha-Dihydroartemisinin methyl ether artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer artemether[inn] beta-Artemether beta-Dihydroartemisinin methyl ether rither |
| | 3 | | Dexamethasone | approved, investigational | Phase 4 | 1909 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Baycadron Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone Dexameth Dexamethansone | Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone acetate Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone sodium phosphate Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamethsone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon Ozurdex PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 | |
| | 4 | | Lumefantrine | approved | Phase 4 | 141 | 82186-77-4 | 6437380 | (+-)-2,7-Dichloro-9-((Z)-P-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol (+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha((dibutylamino)methyl)fluorene-4-methanol (+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol 120583-69-9 2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol 2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol 2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol 2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol 82186-77-4 AC-4542 AC1O5NKD Benflumetol Bio-0132 C30H32Cl3NO CHEBI:156095 | CHEMBL38827 CID6437380 Coartem D03821 DB06708 DL-Benflumelol HSDB 7210 I14-7746 LS-177674 Lumefantrine Lumefantrine (INN) Lumefantrine [INN:BAN] MolPort-006-394-826 NCGC00167490-01 UNII-F38R0JR742 dl-Benflumelol | |
| | 5 | | Miconazole | approved, investigational | Phase 4 | 3026 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv Desenex DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Makesense Micantin (nitrate) Micatin | Miconasil Nitrate Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Oravig Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 Rash Relief Antifungal SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole |
| | 6 | | Bupivacaine | approved, investigational | Phase 4 | 964 | 2180-92-9 | 2474 | ( inverted exclamation markA)-bupivacaine (+-)-Bupivacaine (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (RS)-bupivacaine 1-Butyl-2',6'-pipecoloxylidide 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 15233-43-9 2180-92-9 38396-39-3 AB00053674 AC-2096 AC1L1DRE AC1Q5LX4 AH 250 AKOS001637202 AR-1A0242 Anekain BPBio1_000298 BRD-A01636364-003-05-2 BSPBio_000270 BSPBio_002607 Bio-0886 Bloqueina Bucaine Bucaine (TN) Bupivacaina Bupivacaina [INN-Spanish] Bupivacaine Bupivacaine (INN) Bupivacaine Carbonate Bupivacaine HCL Bupivacaine HCL KIT Bupivacaine Hydrochloride Bupivacaine Monohydrochloride, Monohydrate Bupivacaine [INN:BAN] Bupivacainum Bupivacainum [INN-Latin] Bupivan C07529 C18H28N2O CBupivacaine CHEBI:3215 CHEMBL1098 CID2474 Carbostesin D07552 DB00297 DL-Bupivacaine DUR-843 DepoBupivacaine | DivK1c_000758 EINECS 218-553-3 EINECS 253-911-2 Exparel HMS2090F12 IDI1_000758 KBio1_000758 KBio2_002004 KBio2_004572 KBio2_007140 KBio3_001827 KBioGR_001516 KBioSS_002004 KST-1A4609 L000695 LAC-43 LS-109841 LS-2222 MLS001361336 Marcaina Marcaine Marcaine HCL Marcaine Spinal MolPort-004-955-820 NCGC00178579-01 NCGC00178579-02 NINDS_000758 NSC119660 Prestwick0_000305 Prestwick1_000305 Prestwick2_000305 Prestwick3_000305 Racemic bupivacaine SMR000058218 SPBio_001558 SPBio_002489 Sensorcaine Sensorcaine-MPF Sensorcaine-MPF Spinal Spectrum2_001589 Spectrum3_000974 Spectrum4_001098 Spectrum5_001483 Spectrum_001524 Transdur-Bupivacaine UNII-Y8335394RO Vivacaine Win 11318 Win 11318 HCl bupivacaine cBupivacaine dl-1-Butyl-2',6'-pipecoloxylidide | |
| | 7 | | Hormone Antagonists | | Phase 4 | 10002 | | | | 8 | | Hormones | | Phase 4 | 11748 | | | | 9 | | HIV Protease Inhibitors | | Phase 4 | 4558 | | | | 10 | | Dexamethasone acetate | | Phase 4 | 1909 | 1177-87-3 | | | 11 | | Gastrointestinal Agents | | Phase 4 | 6401 | | | | 12 | | glucocorticoids | | Phase 4 | 3896 | | | | 13 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 4 | 9988 | | | | 14 | | Immunologic Factors | | Phase 4 | 18483 | | | | 15 | | Triamcinolone hexacetonide | | Phase 4 | 448 | | | | 16 | | Analgesics | | Phase 4, Phase 2, Phase 3 | 9358 | | | | 17 | | Triamcinolone diacetate | | Phase 4 | 448 | | | | 18 | | triamcinolone acetonide | | Phase 4 | 448 | | | | 19 | | Peripheral Nervous System Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 18510 | | | | 20 | | Protease Inhibitors | | Phase 4 | 4558 | | | | 21 | | Immunosuppressive Agents | | Phase 4 | 10422 | | | | 22 | | Dexamethasone 21-phosphate | | Phase 4 | 1909 | | | | 23 | | Antiparasitic Agents | | Phase 4 | 1854 | | | | 24 | | Artemether-lumefantrine combination | | Phase 4 | 134 | | | | 25 | | Artemisinine | | Phase 4 | 202 | | | | 26 | | Antimalarials | | Phase 4 | 1058 | | | | 27 | | Anti-Infective Agents | | Phase 4 | 17220 | | | | 28 | | Anthelmintics | | Phase 4 | 379 | | | | 29 | | Antifungal Agents | | Phase 4 | 3015 | | | | 30 | | Artemisinins | | Phase 4 | 202 | | | | 31 | | Antiprotozoal Agents | | Phase 4 | 1730 | | | | 32 | | Antineoplastic Agents, Hormonal | | Phase 4 | 4256 | | | | 33 | | BB 1101 | | Phase 4 | 1909 | | | | 34 | | Anesthetics | | Phase 4, Phase 2 | 7385 | | | | 35 | | Central Nervous System Depressants | | Phase 4, Phase 2, Phase 3 | 10016 | | | | 36 | | Anti-Inflammatory Agents | | Phase 4 | 8478 | | | | 37 | | Anesthetics, Local | | Phase 4 | 2347 | | | | 38 | | Antiemetics | | Phase 4 | 3213 | | | | 39 | | Carbamazepine | approved, investigational | Phase 2, Phase 3 | 118 | 298-46-4 | 2554 | 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide 298-46-4 5-Carbamoyl-5H-dibenz(b,f)azepine 5-Carbamoyl-5H-dibenz[b,F]azepine 5-Carbamoyl-5H-dibenz[b,f]azepine 5-Carbamoyl-5H-dibenzo(b,F)azepine 5-Carbamoyl-5H-dibenzo(b,f)azepine 5-Carbamoyldibenzo(b,f)azepine 5-Carbamyl-5H-dibenzo(b,F)azepine 5-Carbamyl-5H-dibenzo(b,f)azepine 5-Carbamyldibenzo(b,f)azepine 5H-Dibenz(b,F)azepine-5-carboxamide 5H-Dibenz(b,f)azepine-5-carboxamide 5H-Dibenz[b,f]azepine-5- carboxamide 5H-Dibenz[b,f]azepine-5-carboxamide 5H-Dibenzo[b,f]azepine-5-carboxamide 85756-57-6 (di-hydrate) AC-10560 AC1L1DXT AC1Q4ZSU AC1Q4ZSV AKOS003235644 Amizepin Amizepine Apo-Carbamazepine Atretol BIDD:GT0479 BIM-0050280.0001 BPBio1_000225 BRD-K71799949-001-06-7 BRN 1246090 BSPBio_000203 BSPBio_001929 Bio-0751 Bipotrol Biston C 4024 C06868 C4024_SIAL C4024_SIGMA C8981_SIAL CARBAMAZEPINE, U.S.P. CAS-298-46-4 CBChromo1_000350 CBZ CDS1_002710 CHEBI:3387 CHEMBL108 CID2554 CPD001227191 Calepsin Carbamazepan Carbamazepen Carbamazepin Carbamazepina Carbamazepina [INN-Spanish] Carbamazepine Carbamazepine (JP15/USP/INN) Carbamazepine ER Carbamazepine [USAN:INN:BAN:JAN] Carbamazepinum Carbamazepinum [INN-Latin] Carbamazépine Carbamezepine Carbatrol Carbatrol extended-release Carbazepin Carbazepine Carbelan ChemDiv1_018966 D00252 DB00564 DivK1c_000388 DivK1c_003750 EINECS 206-062-7 EU-0100292 Epitol Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine Equetro Equetro (TN) Finlepsin G 32883 G-32883 Geigy 32883 HMS1568K05 | HMS1920I17 HMS2090M07 HMS2091O19 HMS501D10 HMS640O02 HSDB 3019 I06-0863 IDI1_000388 KBio1_000388 KBio2_000516 KBio2_003084 KBio2_005652 KBio3_001149 KBioGR_000724 KBioSS_000516 Karbamazepin LS-60362 Lexin Lopac-C-4024 Lopac0_000292 MLS000069652 MLS001055475 MLS001074172 Mazepine MolPort-000-710-574 NCGC00015234-01 NCGC00015234-02 NCGC00015234-03 NCGC00015234-07 NCGC00015234-13 NCGC00023877-03 NCGC00023877-04 NCGC00023877-05 NCGC00023877-06 NCGC00023877-07 NCGC00023877-08 NINDS_000388 NSC 169864 NSC169864 Neurotol Neurotop retard Novo-Carbamaz Nu-Carbamazepine Oprea1_790775 Prestwick0_000052 Prestwick1_000052 Prestwick2_000052 Prestwick3_000052 Prestwick_104 S1693_Selleck SAM002264603 SMR000058201 SMR001227191 SPBio_000170 SPBio_002124 SPD-417 SPECTRUM1500159 STK177357 Sirtal Spectrum2_000125 Spectrum3_000325 Spectrum4_000262 Spectrum5_000936 Spectrum_000096 Stazepin Stazepine Taro-Carbamazepine Taro-Carbamazepine Cr Tegretal Tegretol Tegretol (TN) Tegretol Chewtabs Tegretol Cr Tegretol XR Tegretol-Xr Telesmin Teril Timonil Trimonil UNII-33CM23913M WLN: T C676 BNJ BVZ ZINC00004785 benzo[b][1]benzazepine-11-carboxamide carbamazepine carbamazepine (Tegretol) nchem.859-comp7 | |
| | 40 | | Lamotrigine | approved, investigational | Phase 2, Phase 3 | 179 | 84057-84-1 | 3878 | 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine 84057-84-1 AC-10298 AC1L1GWT BIDD:GT0794 BW 430C BW-430C Bio-0056 C047781 CHEBI:138727 CHEBI:6367 CHEMBL741 CID3878 CPD000058464 Crisomet D00354 DB00555 Desitin Brand of Lamotrigine EINECS 281-901-8 EU-0100688 EUR-1048 Faes Brand of Lamotrigine GI 267119X GW 273293 Glaxo Wellcome Brand of Lamotrigine GlaxoSmithKline Brand of Lamotrigine HMS2051C10 HMS2089M08 HMS2093P21 HSDB 7526 Juste Brand of Lamotrigine L 3791 L3791_SIGMA LS-155249 | Labileno Lamictal Lamictal (TN) Lamictal CD Lamictal Cd Lamictal ODT Lamictal XR Lamictin Lamiktal Lamitor Lamotrigina Lamotrigina [Spanish] Lamotrigine Lamotrigine (JAN/USAN/INN) Lamotrigine [USAN:INN:BAN] Lamotriginum Lamotriginum [Latin] Lopac-L-3791 Lopac0_000688 MLS000069685 MLS000759486 MLS001077325 MolPort-003-666-744 NCGC00015605-01 NCGC00015605-02 NCGC00015605-06 NCGC00015605-08 NCGC00022936-02 NCGC00022936-04 NCGC00022936-05 NSC746307 SAM001246697 SMP2_000303 SMR000058464 STK628377 Tocris-1611 UNII-U3H27498KS ZINC00013156 lamotrigine | |
| | 41 | | Amifostine | approved, investigational | Phase 3 | 81 | 20537-88-6 | 2141 | Amifostina Amifostine Amifostine Ethiofos Amifostinum Aminopropylaminoethyl Thiophosphate | Apaetp Ethiofos Ethyol Gammaphos SAPEP WR-1065 | |
| | 42 | | Excitatory Amino Acids | | Phase 2, Phase 3 | 1109 | | | | 43 | | Neurotransmitter Agents | | Phase 2, Phase 3, Phase 1 | 14795 | | | | 44 | | Tranquilizing Agents | | Phase 2, Phase 3 | 3597 | | | | 45 | | Sodium Channel Blockers | | Phase 2, Phase 3 | 1180 | | | | 46 | | Psychotropic Drugs | | Phase 2, Phase 3 | 5501 | | | | 47 | | Calcium, Dietary | | Phase 2, Phase 3 | 4678 | | | | 48 | | Anticonvulsants | | Phase 2, Phase 3 | 2249 | | | | 49 | | Excitatory Amino Acid Antagonists | | Phase 2, Phase 3 | 1095 | | | | 50 | | Antimanic Agents | | Phase 2, Phase 3 | 663 | | |
Interventional clinical trials: (show all 41)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain | Completed | NCT01447108 | Phase 4 | | 2 | A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®) | Completed | NCT01256658 | Phase 4 | | 3 | Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain | Completed | NCT02024724 | Phase 4 | | 4 | Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia | Completed | NCT00913107 | Phase 2, Phase 3 | | 5 | A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia | Recruiting | NCT01364259 | Phase 3 | | 6 | CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain | Terminated | NCT00122915 | Phase 3 | | 7 | Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain | Withdrawn | NCT01920087 | Phase 2, Phase 3 | | 8 | Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception | Withdrawn | NCT00349050 | Phase 2, Phase 3 | | 9 | A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia | Completed | NCT01540630 | Phase 2 | | 10 | Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain | Completed | NCT00001725 | Phase 2 | | 11 | RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery | Recruiting | NCT02708810 | Phase 2 | | 12 | Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia | Recruiting | NCT02473016 | Phase 2 | | 13 | Botulinum Toxin for the Treatment of Trigeminal Neuralgia | Recruiting | NCT02088632 | Phase 2 | | 14 | Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients | Enrolling by invitation | NCT00866424 | Phase 1, Phase 2 | | 15 | Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. | Not yet recruiting | NCT02662972 | Phase 1, Phase 2 | | 16 | Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique | Not yet recruiting | NCT02624661 | Phase 1, Phase 2 | | 17 | Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve | Terminated | NCT01886313 | Phase 2 | | 18 | Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain | Terminated | NCT01849796 | Phase 2 | | 19 | Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain | Completed | NCT01053845 | Phase 1 | | 20 | Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. | Recruiting | NCT02321566 | Phase 1 | | 21 | PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers | Recruiting | NCT02359344 | Phase 1 | | 22 | Transcranial Magnetic Stimulation for Facial Pain | Not yet recruiting | NCT02633306 | Phase 1 | | 23 | Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia | Completed | NCT00203229 | | | 24 | Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia | Completed | NCT00004431 | | | 25 | The Effect of Intravenous Lidocaine on Trigeminal Neuralgia | Completed | NCT01955967 | | | 26 | EEG Monitoring to Assess Emergence From Neuroanesthesia | Completed | NCT00443807 | | | 27 | A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain | Completed | NCT00336349 | | | 28 | Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI | Completed | NCT00243152 | | | 29 | A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia | Recruiting | NCT01364285 | | | 30 | A Nasal Applicator for the Treatment of Trigeminal Neuralgia | Recruiting | NCT01761604 | | | 31 | Comparison Between Radiofrequency and Balloon Compression in the Treatment of Idiopathic Trigeminal Neuralgia | Recruiting | NCT02427074 | | | 32 | Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia | Recruiting | NCT01364272 | | | 33 | Hippocampal Radiation Exposure and Memory | Recruiting | NCT00603694 | | | 34 | Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy | Recruiting | NCT01632657 | | | 35 | HBOT Late Radiation Tissue Injury | Recruiting | NCT02425215 | | | 36 | The Efficacy of L-cysteine in Prevention of Cluster Headache | Recruiting | NCT02310828 | | | 37 | fMRI and DTI of Cerebellar Responses to Pain in the Human Trigeminal System | Active, not recruiting | NCT01738126 | | | 38 | Sensory Retraining Facilitates Sensory Recovery After Mandibular Nerve Injury | Active, not recruiting | NCT01586598 | | | 39 | RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT | Enrolling by invitation | NCT01885299 | | | 40 | Magnetic Resonance Imaging Study on Patients With Trigeminal Neuralgia | Not yet recruiting | NCT02713646 | | | 41 | CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap | Withdrawn | NCT01932255 | |
Inferred drug relations via UMLS65/NDF-RT43:
|
